Gene: METTL23
Official Full Name: methyltransferase 23, arginineprovided by HGNC
Gene Summary: The protein encoded by this gene functions as a transcription factor regulator in the transcriptional pathway for human cognition. It is a partner of the alpha subunit of the GA-binding protein transcription factor. Mutations in this gene cause mild autosomal recessive intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28013 | METTL23 Knockout cell line (HeLa) | Human | METTL23 | 1:3~1:6 | Negative | Online Inquiry |
KO28014 | METTL23 Knockout cell line (HCT 116) | Human | METTL23 | 1:2~1:4 | Negative | Online Inquiry |
KO28015 | METTL23 Knockout cell line (HEK293) | Human | METTL23 | 1:3~1:6 | Negative | Online Inquiry |
KO28016 | METTL23 Knockout cell line (A549) | Human | METTL23 | 1:3~1:4 | Negative | Online Inquiry |
METTL23 Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate advanced genetic research and functional studies targeting the METTL23 gene, which plays a crucial role in cellular methylation processes. This product enables researchers to explore the biological consequences of METTL23 loss-of-function in a controlled environment, providing insights into gene regulation, cellular metabolism, and potential therapeutic pathways.
The key functions of the METTL23 Gene Knockout Cell Lines revolve around their ability to accurately mimic the gene's absence, permitting researchers to dissect the molecular mechanisms underlying METTL23's involvement in cellular functions. These knockout models enable the evaluation of gene interactions, signaling pathways, and metabolic activities that could be influenced by METTL23 perturbation, thus shedding light on its role in health and disease.
Scientifically, the importance of METTL23 Gene Knockout Cell Lines extends into various research domains, including cancer biology, neurobiology, and metabolic studies. In clinical settings, understanding how METTL23 contributes to disease mechanisms could lead to the identification of novel therapeutic targets and biomarkers, advancing personalized medicine approaches.
Compared to alternative cell line models, METTL23 Gene Knockout Cell Lines provide a high specificity for studying the direct effects of METTL23 disruption without confounding factors associated with partial inhibition or off-target effects. Our meticulously developed models offer consistent genetic backgrounds and robust performance in assays, ensuring reliable and reproducible results.
For researchers and clinicians looking to enhance their investigations into gene function and therapeutics, the METTL23 Gene Knockout Cell Lines offer unparalleled value. Their capability to deliver precise experimental outcomes makes them a go-to resource for those aiming to elucidate the regulatory mechanisms of this important gene.
At our company, we are committed to advancing scientific research by providing high-quality, cutting-edge biological products that empower researchers to make innovative discoveries. Our expertise ensures that our offerings meet the highest standards of scientific accuracy and reliability.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.